Exosens Shares Drop 2.91% to €63.30, Bucking the Trend of an Euphoric CAC 40
Exosens shares fell by 2.91% to €63.30 in mid-session trading on Wednesday, while the CAC 40 index rose by 3.11% to 8,312.84 points. The company, specializing in night vision and imaging technology for defense, is moving against the upward trend of European markets, which are buoyed by geopolitical easing in the Middle East. However, the stock still maintains a year-on-year gain of 74.38%.
A Lone Decline in a Strongly Rising Paris Market
European indices surged on Wednesday amid diplomatic rapprochement between Washington and Tehran. The SBF 120 is up 3.05% and the DAX has gained 2.58%. Brent crude has dropped nearly 8.6% to $100.44, as the market removes some of the war premium built into prices. Exosens stands out with its isolated decline, with no specific news identified for the day. The geopolitical relaxation mechanically weighs on the sentiment around defense stocks, a sector that encompasses most of the group's activities. As a reminder, at the end of April, the company reported a 19.7% increase in first-quarter revenue to €122.6 million, driven by demand for night vision for defense.
Below the 50-Day Average, at the Lower End of the Bollinger Bands
At €63.30, Exosens has moved below its 50-day moving average of €64.33 after testing it for several sessions. The price is in the lower part of the Bollinger Bands, about 2.5% above the lower boundary set at €61.76. The RSI at 53 remains neutral, with no overbought or oversold signals. The 200-day moving average, at €50.71, remains well behind, reflecting the stock's fundamentally upward trajectory. The 2025 guidance communicated during the first nine months' earnings report targets revenue growth at the upper end of the 15-20% range and adjusted EBITDA growth at the lower end of the 20-25% range. Technical support is located at €57.50. The next key date on the calendar is the general meeting on May 22, 2026.
